[Assessment of the use of a multicomponent drug in the treatment of new cases of pulmonary tuberculosis].

  • Olena Semenova
  • Published 2003 in Problemy tuberkuleza i boleznei legkikh

Abstract

The multicomponent drug Mairin-P that contains isoniazid, 60 mg, rifampicin, 120 mg, pyrazinamide, 300 mg, and ethambutol hydrochloride, 225 mg, has been pharmacokinetically and clinically studied. There was no significant difference in the pharmacokinetic parameters of rifampicin as a component of Mairin-P and in combination with antitubercuous agents as… (More)

Topics

Cite this paper

@article{Semenova2003AssessmentOT, title={[Assessment of the use of a multicomponent drug in the treatment of new cases of pulmonary tuberculosis].}, author={Olena Semenova}, journal={Problemy tuberkuleza i boleznei legkikh}, year={2003}, volume={11}, pages={22-5} }